|
All Business Categories
|
Genelabs Technologies , Inc.
California, USA Genelabs Technologies, Inc. is a biopharmaceutical company focused on the discovery and development of pharmaceutical products to improve human health. We have built drug discovery... AlphaRx Inc. Ontario, Canada AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (wh... IntraBiotics Pharmaceuticals , Inc. California, USA Developing biopharmaceutical products for the prevention and treatment of serious and life-threatening infections. Momenta Pharmaceuticals , Inc. Massachusetts, USA Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of e... Sirtris Pharmaceuticals Inc. Massachusetts, USA Sirtris PharmaceuticalsÔ is a biopharmaceutical company developing novel therapeutics that modulate sirtuins. Sirtris has the leading sirtuin intellectual property estate and know-... Massachusetts, USA AVANT is a biopharmaceutical company that uses novel applications of immunology to prevent and treat diseases. We have assembled a broad portfolio of technologies and intellectual ... BioDelivery Sciences International , Inc. North Carolina, USA We are a specialty pharmaceutical company that is exploiting our licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in ... Hollis-Eden Pharmaceuticals , Inc. California, USA Hollis-Eden Pharmaceuticals, Inc. is developing through its Hormonal Signaling Technology Platform a proprietary new class of small molecule compounds that are metabolites or synth... Cellular Genomics Inc. Connecticut, USA Cellular Genomics Inc. (CGI) is a privately held genomics-based biopharmaceutical company that is pioneering a highly integrated chemical genetics platform for drug discovery and d... CeNeS Pharmaceuticals plc CB24, United Kingdom CeNeS Pharmaceuticals plc (AIM: CEN), the biopharmaceutical company developing a new generation of pain management products, announces interim results for the six months ended 30 J...
First
Prev
[15]
[30]
[44]
[59]
[60]
[61]
[62]
[63]
[64]
[65]
[66]
[67]
[68]
69
[70]
[71]
[72]
[73]
[74]
[75]
[76]
[77]
[78]
[122]
[167]
[211]
Next
Last
|
